HYQVIA
161503
Approved mab completed
Quick answer
HYQVIA for Primary Immunodeficiency Diseases (PID) is a Approved program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 2 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Primary Immunodeficiency Diseases (PID)
- Phase
- Approved
- Modality
- mab
- Status
- completed